Skip to main content

Advertisement

Log in

Two web-based dynamically interactive nomograms and risk stratification systems for predicting survival outcomes and guiding treatment in non-metastatic nasopharyngeal carcinoma

  • Research
  • Published:
Journal of Cancer Research and Clinical Oncology Aims and scope Submit manuscript

Abstract

Background

A nomogram is a valuable and easily accessible tool for individualizing cancer prognosis. This study aims to establish and validate two prognostic nomograms for long-term overall survival (OS) and cancer‐specific survival (CSS) in non-metastatic nasopharyngeal carcinoma (NPC) patients and to investigate the treatment options for the nomogram-based risk stratification subgroups.

Methods

A total of 3959 patients with non-metastatic NPC between 2004 and 2015 were identified from the Surveillance, Epidemiology, and End Results (SEER) database. The patients were randomly allocated to the training and validation cohorts in a 7:3 ratio. Prognostic nomograms were constructed to estimate OS and CSS by integrating significant variables from multivariate Cox regression employing a backward stepwise method. We examined the correlation indices (C-index) and areas under the curves (AUC) of time-dependent receiver operating characteristic curves to assess the discriminative ability of our survival models. The comprehensive enhancements of predictive performance were evaluated with net reclassification operating improvement (NRI) and integrated discrimination improvement (IDI). Reliability was validated using calibration plots. Decision curve analysis (DCA) was used to estimate clinical efficacy and capability. Finally, the nomogram-based risk stratification system used Kaplan–Meier survival analysis and log-rank tests to examine differences between subgroups.

Results

The following independent parameters were significant predictors for OS: sex, age, race, marital status, histological type, median household income, AJCC stage tumor size, and lymph node size. Except for the race variables mentioned above, the rest were independent prognostic factors for CSS. The C-index, AUC, NRI, and IDI indicated satisfactory discriminating properties. The calibration curves exhibited high concordance with the exact outcomes. Moreover, the DCA demonstrated performed well for net benefits. The prognosis significantly differed between low- and high-risk patients (p < 0.001). In a treatment-based stratified survival analysis in risk-stratified subgroups, chemotherapy benefited patients in the high-risk group compared to radiotherapy alone. Radiotherapy only was recommended in the low-risk group.

Conclusions

Our nomograms have satisfactory performance and have been validated. It can assist clinicians in prognosis assessment and individualized treatment of non-metastatic NPC patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10
Fig. 11
Fig. 12

Similar content being viewed by others

Data availability

SEER is a widely recognized source of cancer statistics in the USA. Researchers can access the data by submitting an authorization request via the official website. On reasonable request, any of the data used in this study can be obtained from the corresponding authors.

Abbreviations

NPC:

Nasopharyngeal carcinoma

SEER:

Surveillance, epidemiology, and end results

OS:

Overall survival

CSS:

Cancer-specific survival

AUC:

The area under the curve

C-index:

Correlation index

NRI:

Net weight classification operational improvement

IDI:

Integrated discrimination improvement

DCA:

Decision curve analysis

AJCC:

American Joint Committee on Cancer

TNM:

Tumor-node-metastasis

EBV:

Epstein–Barr virus

KSCC:

Keratinizing squamous cell carcinoma

DNKC:

Differentiated non-keratinizing carcinoma

UNKC:

Undifferentiated non-keratinizing carcinoma

CI:

Confidence interval

HR:

Hazard ratio

References

Download references

Acknowledgements

We are incredibly grateful for the SEER database that is publicly available.

Funding

The National Natural Science Foundation of China (No.82172346), and the Technology and Innovation Commission of the Guangzhou Science Association of China (No.202102010087), supported the project.

Author information

Authors and Affiliations

Authors

Contributions

HZ designed and developed the conceptual framework, collected the data, performed the statistical analysis, and drafted the manuscript. ML critically revised and created the manuscript. Both authors approved the final manuscript.

Corresponding author

Correspondence to Min-Min Li.

Ethics declarations

Conflict of interest

It is declared that none of the authors have any commercial or financial relationships that could be considered a conflict of interest.

Ethical approval and patient consent

The collection of SEER data information is permitted by Section 411 of the Public Health Service Act (42 USC 285a). Study subjects are protected by the Privacy Act of 1974. SEER database releases updated research data each spring based on November submissions. Since the data contains no personally identifying information, informed consent is not required. Data in the SEER Registry are publicly available, and we have been granted access to them (License Number: xIFKJ11a).

Consent to publish

All authors consent to the publication of the manuscript.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zuo, H., Li, MM. Two web-based dynamically interactive nomograms and risk stratification systems for predicting survival outcomes and guiding treatment in non-metastatic nasopharyngeal carcinoma. J Cancer Res Clin Oncol 149, 15969–15987 (2023). https://doi.org/10.1007/s00432-023-05363-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00432-023-05363-0

Keywords

Navigation